Drug Czar Nominee Led Effort to Undermine Opioid Abuse Fight

Drug Czar Nominee Led Effort to Undermine Opioid Abuse Fight

Drug Czar Nominee Led Effort to Undermine Opioid Abuse Fight

A joint Washington Post and "60 Minutes" report said that Marino, a Pennsylvania Republican, sponsored legislation that made it harder for the Drug Enforcement Administration to go after drug companies distributing opioids even as the rate of overdose deaths doubled between 1999 and 2015.

A White House official with knowledge of the process wasn't sure the declaration will be completed next week.

Claire McCaskill, who called Marino's withdrawal "the right decision" in a press release, said Monday she would introduce legislation to repeal it.

After national scrutiny, Pennsylvania Representative Tom Marino has withdrawn from consideration to lead the National Drug Control Policy office - a position commonly called the Drug Czar. Trump did not say when he and the congressman spoke. It was not immediately clear to whom Marino was referring.

Trump told reporters at a Rose Garden news conference that he will look at reports by The Washington Post and CBS News "very closely", adding: "If I think it's one per cent negative to doing what we want to do, I will make a change".


Before running for Congress, Marino abruptly resigned as US attorney in 2007 amid a justice department investigation related to allegations that he helped a businessman get a casino license in Pennsylvania, The Morning Call reported. West Virginia Senator Joe Manchin, who has been vocal about his disapproval of the nomination, applauded the move.

Manchin scolded the Obama administration for failing to "sound the alarm on how harmful that bill would be for our efforts to effectively fight the opioid epidemic" that kills an estimated 142 people a day nationwide.

Tom Marino talks during an episode of The Wilkow Majority on July 21, 2016 in Cleveland, Ohio.

"Such unfettered discretion concerned the patient advocacy and drug manufacturing community because an immediate suspension order cuts off all drugs from a distributor, including those intended for legitimate users", Hatch said.

The Justice Department, under which the DEA operates, said Tuesday it will review the law's impact on the government's enforcement powers. Legislators are signaling an intention to revoke the 2016 law that made the drugs more readily available.

Related news